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Abstract
Numerous cardiac diseases, including myocardial infarction (MI) and chronic heart failure, have been associated with
cardiomyocyte apoptosis. Promoting cell survival by inhibiting apoptosis is one of the effective strategies to attenuate
cardiac dysfunction caused by cardiomyocyte loss. miR-24 has been shown as an anti-apoptotic microRNA in various animal
models. In vivo delivery of miR-24 into a mouse MI model suppressed cardiac cell death, attenuated infarct size, and rescued
cardiac dysfunction. However, the molecular pathway by which miR-24 inhibits cardiomyocyte apoptosis is not known. Here
we found that miR-24 negatively regulates mouse primary cadiomyocyte cell death through functioning in the intrinsic
apoptotic pathways. In ER-mediated intrinsic pathway, miR-24 genetically interacts with the CEBP homologous gene CHOP
as knocking down of CHOP partially attenuated the induced apoptosis by miR-24 inhibition. In mitochondria–involved
intrinsic pathway, miR-24 inhibits the initiation of apoptosis through suppression of Cytochrome C release and Bax
translocation from cytosol to mitochondria. These results provide mechanistic insights into the miR-24 mediated anti-
apoptotic effects in murine cardiomyocytes.
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Introduction
Cardiac disease is the leading cause of death and disability in
the developed countries. In the US over five million patients suffer
from progressive cardiac dysfunction, known as heart failure. A
variety of animal and human studies have demonstrated that
apoptosis (programmed cell death) contributes significantly to
cardiomyocyte loss during the development and progression of
heart failure [1,2]. Because cardiomyocytes are terminally
differentiated and have little potential for division, preventing cell
death has important implications in the treatment of cardiovas-
cular disease [3]. Introduction of new cardiac cells by cell-based
therapeutic approaches is promising, but promoting survival of
newly introduced cardiomyocytes remains challenging [4,5,6].
Apoptosis is a highly conserved and regulated cell death process
that plays a fundamental role in myriad physiological processes.
The diverse stresses and conditions that trigger apoptosis
ultimately converge to activate a family of aspartic acid–specific
cysteine proteases, called caspases [7,8]. Activation of caspases is
central to apoptosis and can be initiated by any of three distinct
mechanisms: (1) ligand binding to death receptors, (2) release of
Cytochrome C from mitochondria, and (3) stress to the
endoplasmic reticulum (ER) [9,10,11].
Alternatively, apoptosis can be triggered through either the
extrinsic pathway or the intrinsic pathway. The extrinsic pathway
is initiated through the stimulation of the transmembrane death
receptors, such as the Fas receptors, located on the cell membrane.
In contrast, the intrinsic pathway is initiated from within the cell
by developmental cues or severe cell stress [7,8]. The mitochon-
dria is considered the central organelle in the intrinsic apoptotic
pathway[10]. However, accumulating evidence suggests that other
organelles, such as the ER, lysosomes, and Golgi apparatus, are
also involved in bridging the pro-apoptotic signaling with cellular
stress [9,12]. In the myocardium, the ER participates in stress-
induced apoptosis, cellular calcium homeostasis, and synthesis of
secretory proteins, such as atrial natriuretic peptide, brain
natriuretic peptide, and vascular endothelial growth factor
[13,14,15]. Dysfunction of the ER might thus contribute to the
pathogenesis of heart disease [13].
Members of the Bcl-2 family proteins are major regulators of
the intrinsic apoptotic pathway and play an important role in
regulating cardiomyocyte apoptosis [16]. The family includes pro-
apoptotic (e.g., Bax, Bid, Bim) and anti-apoptotic (e.g., Bcl-2, Bcl-
xL) members [16,17]. Overexpression of anti-apoptotic Bcl-2
family proteins protects cardiomyocytes from doxorubicin and
hypoxia-induced cell death [16]. Bax, the Bcl2-associated X
protein, forms heterodimers with Bcl-2 and promotes pro-
grammed cell death [18,19]. Bax is generally sequestered in the
cytosol and trafficked from the cytosol into mitochondria upon
apoptotic stimuli [20,21,22]. Bax translocation into mitochondria
triggers the release of cytochrome c [23,24]. The released
cytochrome c from the mitochondria cleaves and activates
caspase-3 and caspase-9 to trigger a series of downstream
apoptotic events [21,22,24].
A more recently discovered mechanism of post-transcriptional
regulation involves a class of small non-coding RNAs, known as
microRNAs (miRNAs) (for reviews [25,26,27,28]). By imperfect
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sequence-specific binding to their mRNA targets, miRNAs
negatively regulates protein expression by degrading target mRNA
or inhibiting translation. miR-24 is one of the microRNAs that
functions in multiple biological processes, including erythroid
differentiation, DNA-repair process, cell cycle regulation and
programmed cell death [29,30,31,32,33,34]. Especially, we and
others showed that miR-24 negatively regulates apoptosis in frogs
and mice [33,35]. Here we studied the molecular mechanisms by
which miR-24 inhibits apoptosis in murine primary cardiomyo-
cytes. By performing a series of epistasis analyses, we found that
miR-24 modulated intrinsic apoptotic pathway including both ER
and mitochondria-involved apoptosis.
Materials and Methods
Primary cardiomyocyte culture and transfection
Primary cardiomyocytes from mouse neonatal hearts were
isolated and maintained as described [36]. Animal protocol was
approved by UNC-Chapel Hill DLAM. All procedures conform to
NIH guidelines. Briefly, hearts were minced and digested with
collagenase type II (Worthington) solution. Digested cells were pre-
plated for 2 hr to enrich cardiomyocytes. The attached cells after
2hr plating were considered to be non-myocytes and discarded,
while the unattached cells were primarily cardiomyocytes. The
cardiomyocyte identity was further confirmed by immunocyto-
chemistry with myocardial markers. Unattached cells were
cultured in DMEM/M199 medium containing 10% FBS at a
density of 104/cm2. Lipofectamine 2000 (Invitrogen)-mediated






39) and miR24mut inhibitor (59-ACCGAGUCAAGUCAUU-
CUUGGC-39) were purchased from Dharmacon and Shanghai
GenePharma Co. siRNA cocktails against Caspase3, Caspase8,
Caspase9, Caspase12, Bim, ATF6, CHOP, JNK, XBP1 were
purchased from Dharmacon (ThermoScientific) as SmartPool
OnTarget siRNAs. For transfection in each well of a six-well plate,
40 pmol of oligos was used.
Chemical reagents
Tunicamycin and thapsigargin were purchased from Sigma and
resuspended in DMSO. Tunicamycin was used at 0.1 mg/ml, and
thapsigargin was used 0.1 mM, according to previous studies
[15,37]. CD95 and camptothecin were purchased from BD
Pharmingen and used at 5 mM per manufacturer’s protocol.
Caspase Inhibitor VI (Z-VAD-FMK) that inhibits all caspases was
purchased from Calbiochem. Caspase-8/FLICE inhibitor (Z-
IETD-FMK), Caspase-9/Mch6 inhibitor (Z-LEHD-FMK) and
Caspase-12 inhibitor (Z-ATAD-FMK) were purchased from
Biovision. All caspase inhibitors were dissolved in DMSO and
kept at 2 mM as 1000X stock solution. For cell treatments, the
aforementioned chemicals were diluted directly in corresponding
media and filtered for sterile conditions.
Flow cytometry
To detect early apoptotic cells (AnnexinV+PI-), dissociated cells
(56105) were washed twice in PBS and resuspended in 1Xbinding
buffer (BD Biosciences). The cells were then stained with
AnnexinV-FITC and propidium iodide (PI) (ready-to-use solu-
tions, BD Biosciences) for 30 minutes in dark and followed by
FACS analysis using Calibur (BD Biosciences).
Quantitative real-time PCR
Total RNA was extracted with the TRizol method (Invitrogen).
RT-PCR was performed using Superscript III first-strand synthesis
system (Invitrogen). qPCR was performed using the ABI 7900HT
(TaqMan, Applied Biosystems) per the manufacturer’s protocols.
Optimized primers from Taqman Gene Expression Array were
used. MicroRNA RT was conducted using Taqman MicroRNA
Reverse Transcription Kit (Applied biosystems). MicroRNA real
time PCR (qRT-PCR) was performed per the manufacturer’s
protocols by using primers from Taqman MicroRNA Assays
(Applied biosystems). Expression levels were normalized to Gapdh
expression and RNU6 (microRNA qPCR).
Semi-quantitative RT-PCR
XBP1 mRNA splicing was determined using semi-quantitative
RT-PCR. The established primers to detect the unspliced form
and spliced form are used as followed: XBP1 forward, 59- CAG
ACT ACG TGC GCC TCT GC -39; XBP1 reverse 59- CTT
CTG GGT AGA CCT CTG GG -39; sXBP1 forward 59- TCT
GCT GAG TCC GCA GCA GG -39; sXBP1 reverse 59- CTC
TAA GAC TAG AGG CTT GG -39. GAPDH was used as an
endogenous control, the primers are: forward, 59- CAT CAA
CGA CCC CTT CAT TGA CCT CAA CTA -39; reverse, 59-
TCC ACG ATG CCA AAG TTG TCA TGG ATG ACC -39.
Western blot
Western blots were performed as described [38]. Mouse
monoclonal anti-Caspase 8 (Sigma), mouse monoclonal anti-
Caspase 9 (Sigma), rabbit anti-Caspase 3 (Sigma), rat monoclonal
anti-Caspase 12 (Sigma), rabbit polyclonal antibody against Bim
(amino acids 4–195 of BimEL form), rabbit anti-Cytochrome C
(Cell Signaling), goat polyconal anti-HP1 (Santa Cruz), rabbit anti-
CoxIV (Cell Signaling), rabbit anti-phospho-JNK (Thr183/
Tyr185) (81E11) (Cell Signaling), rabbit anti-JNK (Cell Signaling),
mouse monoclonal anti-CHOP (L63F7) (Cell Signaling), rabbit
anti-Apaf-1 (Cell Signaling), rabbit anti-Bcl2 (Cell Signaling),
rabbit polyclonal anti-ATF-6 (Santa Cruz), rabbit anti-Bax (Cell
Signaling) were all used at a 1:1000 dilution for western blots.
Results
miR-24 functions in the intrinsic apoptosis pathway
We and others have previously shown that miR-24 negatively
regulates apoptosis in several different cell types including
cardiomyocytes both in vitro and in vivo. We demonstrated that
miR-24 level is acutely down-regulated upon cardiac injury, in vivo
delivery of miR-24 confers protective effects in infarcted heart
[35]. However the molecular pathway involving miR-24 is largely
unknown. Given the critical anti-apoptotic role of miR-24 in the
ischemic heart, it is important to determine the mechanisms by
which miR-24 inhibits apoptosis in cardiomyocytes. Apoptosis can
be induced via the intrinsic pathway, which involves Bcl-2 family
proteins, or via the extrinsic pathway, which involves death
receptors such as CD95 (Fas) [7,8]. To determine in which
apoptotic pathway miR-24 functions, we treated the cardiomyo-
cytes with CD95/Fas or Campothecin to induce apoptosis by
activating the extrinsic or intrinsic pathway, respectively. Subse-
quently, we delivered miR-24 mimic using our established
protocol and optimized dosage [35]. The induction of miR-24
level was confirmed and the specificity of the mimic/inhibitor was
validated using luciferase sensor experiment as documented before
[35]. The treated cells were then stained with AnnexinV and
propidium iodide (PI) followed by flow cytometric analysis to
determine the rate of apoptosis. We found that introduction of
miR-24 in Cardiomyocyte Apoptosis
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miR-24 significantly attenuated the increased percentage of
AnnexinV+PI- early apoptotic cells induced by camptothecin
(18% to 12%, p,0.05), but not by Fas (18% to 17%, p.0.05)
(Fig. 1A and B). These data suggest that expression of miR-24
inhibited camptothecin-induced intrinsic apoptosis but not Fas-
induced extrinsic apoptosis.
The extrinsic pathway via the death receptor involves Caspase
8, while the intrinsic mitochondrial pathway activates Caspase 9,
and endoplasmic reticulum (ER) stress-mediated apoptosis acti-
vates Caspase12 [7,8]. To confirm the observation we made using
Fas and Camptothecin and further dissect the apoptotic pathways
involving miR-24, we treated the miR-24 inhibitor (tested and
validated in [35]) transfected cardiomyocytes with a series of
Caspase inhibitors and assessed the degree of apoptosis inhibition.
Consistent with the Fas data, inhibition of Caspase 8 using Z-
IETD-FMK did not alleviate the increased apoptosis induced by
miR-24 inhibition. Interestingly, inhibiting Caspase 9 or Caspase
12, both of which are involved in the intrinsic apoptosis,
significantly decreased the percentage of apoptotic cells induced
by miR-24 inhibition (Fig.1C). Inhibiting all Caspases by Z-VAD-
FMK completely rescued the apoptotic effects caused by miR-24
inhibition. As an alternative method, we utilized the siRNA
SmartPool (see method, a siRNA cocktail containing 3,5 different
siRNA sequences against one gene to minimize the off-target
effect) to knock-down the Caspase genes individually to examine
the effect on induced apoptosis by miR-24 inhibition. Knocking-
down efficiency of each Caspase was validated by qPCR. We
observed consistent 70-90% reduction in the expression of each
gene with the siRNA SmartPool (Fig.1E). Knocking-down
Caspase 9 or Caspase 12, but not Caspase 8, resulted in a partial
rescue of increased apoptosis caused by miR-24 inhibitor.
Meanwhile, knocking-down the final ‘‘executor Caspase’’ -Caspase
3 completely reversed the increased apoptosis by miR-24
inhibition (Fig. 1D). Therefore, these data collectively suggest that
miR-24 regulates intrinsic but not extrinsic apoptosis.
miR-24 modulates ER-mediated intrinsic apoptosis
In general, intrinsic apoptotic pathways can be initiated in ER
or mitochondria of the cardiomyocytes. Next, we wanted to
investigate the contribution of miR-24 to distinct intrinsic
apoptotic pathways. To induce ER stress-mediated apoptosis, we
challenged the cardiomyocytes pharmacologically with tunicamy-
cin and thapsigargin. Tunicamycin is an inhibitor of N-glycosyl-
ation in the ER, while thapsigargin disrupts intracellular calcium
homeostasis. As previously reported, treatment of cardiomyocytes
with tunicamycin or thapsigargin caused an increase in the
percentage of AnnexinV+ cells and Caspase-12 expression and
cleavage (Fig.2 and data not shown) [39]. To test whether miR-24
could attenuate ER stress-induced apoptosis, we expressed miR-24
in cardiomyocytes treated with tunicamycin or thapsigargin.
Compared to mock transfection, miR-24 expression significantly
inhibited tunicamycin or thapsigargin induced apoptosis
(Fig.2A and B).
It is generally considered that Caspase-12 is the initiator caspase
in ER-stress-mediated apoptosis based on the observation that
Caspase-12 processing (synthesized and cleaved) occurs during
ER-stress induced apoptosis. Therefore, we tested whether miR-24
had impact on the Caspase-12 expression level and processing. By
performing western blot, we found protein levels of both non-
cleaved and cleaved forms of Caspase 12 were reduced when miR-
24 was overexpressed (Fig. 2C). In contrary, accumulation of both
forms of Caspase 12 was observed when miR-24 inhibitor was
introduced into the cells.
MicroRNAs regulate downstream targets by imperfect binding
of their ‘‘seed sequence’’, the 6-8 nucleotides at the 59 end of a
miRNA that is thought to be an important determinant of target
specificity, to the 39 UTR of target genes. To determine that the
regulation of miR-24 on Caspase expression is indeed through
binding of its seed sequence to downstream targets, we designed
additional controls where the seed sequence of miR-24 mimic and
inhibitor were mutated. We rationalize that if the alteration in
protein levels is indeed due to the changes of miR-24 activity, the
effects we observed using miR-24 mimic or inhibitor would be
abolished when using mutated forms of mimic or inhibitor.
Indeed, when we transfected cells with miR-24mut mimic and
inhibitor, the alteration in proteins levels of Caspase12 and Bim
with miR-24 mimic or inhibitor was diminished suggesting the
effects caused by miR-24 mimic and inhibitor are specific (Fig.2C).
Furthermore, we performed luciferase assay to test if miR-24
directly regulates Caspase 12 through binding to its 39UTR. Co-
transfection of miR-24 mimic or inhibitor with the luciferase
reporter that contains the 39UTR region of Caspase 12 did not
result in a significant change in the luciferase activity when
compared to the controls (Figure S1). These data suggest that the
inhibition of Caspase 12 protein levels by miR-24 is indirect,
possibly through Bim or other direct target(s) in this pathway.
Anti-apoptotic effect of miR-24 overexpression is
associated with decreased CHOP activity in the ER
pathway
Based on the data above, we conclude that miR-24 is involved
in regulating ER-mediated apoptosis in cardiomyocytes. Next, we
want to identify the specific pathway(s) in ER-mediated apoptosis
that involves miR-24. One of the downstream effects of ER stress
is the activation of unfolded protein response (UPR). The
accumulation of improperly folded proteins in the ER leads to
adaptive responses, collectively known as UPR that induces the
expression of genes encoding protein chaperones and folding
catalysts. The ER stress-induced transcription factors activating
transcription factor 6 (ATF6) and X-box binding protein 1 (XBP1)
serve to up-regulate ER chaperone proteins and acts upstream to
other UPR pathways. In order to determine whether miR-24
exerts its effects on ER pathway by regulating UPR, we examined
several key events in UPR in the presence and absence of miR-24.
First, we determined if altered expression of miR-24 affected the
transcription and translation of ATF6 by qPCR and western blot.
We found overexpression or inhibition of miR-24 did not affect
ATF6 mRNA or protein level (Figure S2A). Next we determined if
miR-24 modulates the translocation of ATF6 from the cytosol to
nucleus, as the nuclear localization of ATF6 is pre-requisite for the
activation of downstream events. We used Actin as the loading
control for cytoplasmic fraction of cells and HP1a as the loading
control for nuclear fraction of the cells. Transfection of cells with
miR-24 mimic or inhibitor resulted in no significant change in the
distribution of cytoplasmic versus nuclear level of ATF6, so do the
miR24mut mimic and inhibitor (Figure S2B).
Another key event of ER-mediated apoptosis is the XBP1
splicing. We designed RT-PCR primers specifically to detect the
un-spliced form and spliced form of XBP1. With tunicamycin
treatment, we observed an increased accumulation of spliced
XBP1 compared to control group, validating the efficiency of our
method to detect both forms (Figure- S2C). To test whether miR-
24 regulates XBP1 splicing, we determined the expression of both
forms of XBP1 in cells with miR-24 overexpression or knocking-
down. We detected no difference in either spliced form or
unspliced form of XBP1 when miR-24 expression was altered
(Figure S2C).
miR-24 in Cardiomyocyte Apoptosis
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Apoptosis signals initiated from the ER can also be mediated by
increased expression of the transcription factor cytosine-cytosine-
adenine-adeninethymine enhancer-binding protein (C/EBP), ho-
mologous protein (CHOP), or activation of c-Jun-N-terminal
kinase (JNK). As with ATF6 and XBP1, we took similar
approaches to determine if miR-24 is involved in these critical
Figure 1. miR-24 inhibits the intrinsic apoptosis pathway. (A) FACS analysis on AnnexinV+PI– - apoptotic cells treated with Camp with (middle
panel) or without miR-24 mimic (right panel). The control group is shown in the left panel. Camp., Camptothecin (B) Quantification on AnnexinV+PI–
cells treated with Fas or Camp with or without miR-24 mimic. (C) Inhibition of Caspase 9, Caspase 12 or Caspase 3, but not caspase 8, rescued the
miR-24 loss-of-function phenotype. Cells were incubated with Z-IETD-FMK, Z-LEHD-FMK, Z-ATAD-FMK or Z-VAD-FMK for assessment of caspase-8, -9, -
12 and pan caspases activity, respectively. (D) Knockdown of Caspase 9, Caspase 12 or Caspase 3, but not Caspase 8, rescued the increased apoptosis
caused by inhibition of miR-24. *, p,0.05; **, p,0.01. Data were analyzed by unpaired Student’s t test. (E) Validation of knockdown efficiency using
siRNA cocktail against Caspase 3, 8, 9 and 12 by qPCR. RQ, Relative Quantification. Error bars represent SEM.
doi:10.1371/journal.pone.0085389.g001
miR-24 in Cardiomyocyte Apoptosis
PLOS ONE | www.plosone.org 4 January 2014 | Volume 9 | Issue 1 | e85389
events. Manipulation of miR-24 levels in cardiomyocytes did not
alter mRNA or protein levels of CHOP or JNK or the
phosphrolation of JNK (Figure S2D, E), suggesting CHOP and
JNK are not directly regulated by miR-24. We then designed
epistasis experiments to test the role of CHOP, JNK, ATF6 and
XBP1 in miR-24 mediated apoptosis. First we used siRNA against
each gene to down regulate their expression (Fig 3A). Knocking
down of ATF6, XBP1, CHOP, JNK and caspases had little effect
on miR-24 expression, suggesting that miR-24 does not function
downstream of these pathways (Fig 3B). However, we observed
that knockdown of CHOP but not any other gene we tested above
attenuated the increased apoptosis induced by miR-24 inhibitor
(Fig.3C). Since increased Bim protein levels appeared to be a
major mediator of apoptosis upon miR-24 inhibition in other cell
types [35,40], we tested whether CHOP could regulate Bim in
murine cardiomyocytes. Indeed, CHOP knockdown resulted in a
decrease in Bim mRNA and protein levels, suggesting that CHOP
normally upregulates Bim as it promotes apoptosis (Fig. 3 D and
E). Thus, miR-24 may negatively regulate ER stress-mediated
apoptosis in part by preventing the increase in Bim protein
associated with CHOP activity. Alternatively, miR-24 could
downregulate Bim expression level to counteract the CHOP
induced Bim upregulation.
miR-24 regulates mitochondrial apoptosis pathway by
inhibiting Bax translocation from cytosol to mitochondria
After we determined the role of miR-24 in ER-mediated
apoptosis, we next assessed its potential role in mitochondria-
mediated apoptosis. The mitochondrial pathway of apoptosis starts
with the permeabilization of the mitochondrial outer membrane,
which then leads to the release of Cytochrome C from
Figure 2. miR-24 modulates ER-mediated apoptosis pathway. (A) miR-24 attenuates thapsigargin and tunicamycin induced cell death
through ER-mediated apoptosis pathway. Mouse cardiomyocytes with or without overexpression of miR-24 were cultured with thapsigargin or
tunicamycin for six hours. Cells were stained with FITC-conjugated Annexin V and PI for flow cytometry. Tha, thapsigargin; Tun, tunicamycin. (B)
Percentage of AnnexinV+PI– cells in Fig. 2A shown as mean 6 SEM. These data are representative of three independent experiments. *, p,0.05. Data
were analyzed by unpaired Student’s t test. (C) Western blot for Caspase 12 and Bim from primary CMs transfected with miR-24 mimic, inhibitor, or
corresponding controls. GAPDH serves as a loading control.
doi:10.1371/journal.pone.0085389.g002
miR-24 in Cardiomyocyte Apoptosis
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mitochondria to cytosol. Cytochrome c in conjunction with
apoptosis protease activating factor (APAF-1) and pro-caspase 9
form an ‘apoptosome’. This complex promotes the activation of
caspase 9, which in turn activates effector caspases that collectively
orchestrate the execution of apoptosis. To determine whether
miR-24 regulates the mitochondrial apoptosis pathway, we first
assessed the Cytochrome C release from mitochondria in primary
Campothecin-treated cardiomyocytes transfected with miR-24
mimic, inhibitor, or controls. Strikingly, we found reduced
translocation of Cytochrome C from the mitochondria to the
cytosol, the key event in mitochondria-mediated apoptosis, when
miR-24 was overexpressed in cardiomyocytes (Fig. 4A left panel).
Conversely, inhibition of miR-24 resulted in increased accumu-
lation of Cytochrome C in the cytosol (Fig. 4A right panel).
Cytosolic or mitochondrial fractions were marked by Caspase 8 or
the cytochrome oxidase IV subunit.
Next, we examined how upstream factors in this pathway were
affected by miR-24. The permeabilization of the mitochondrial
outer membrane, the initial step of mitochondrial-induced
apoptosis, can be regulated by a variety of Bcl2 family
proteins[10]. Among them, the translocation of various Bcl2
family proteins from the cytosol to the mitochondria (or vice versa)
is a key event that results in their pro- or anti-apoptotic effects. We
therefore examined the expression levels and cellular localization
of several key Bcl2 family members including Bcl2, Bax, Bak1 and
Bclx in the cardiomyocytes with loss or gain of function of miR-24.
We first examined if manipulation of miR-24 would affect the
transcription and translation of Bax. We found that neither
overexpression nor inhibition of miR-24 resulted in changes in
mRNA level of Bax (Fig. 4B). In order to test whether miR-24
modulates Bax translocation in the mitochondria-mediated
apoptosis pathway, we separated the cytosolic and mitochondrial
fraction of the primary cardiomyocytes and determined the
protein levels in the corresponding fraction with altered expression
of miR-24. We used CoxIV and Caspase 8 as the positive controls
to demonstrate the successful fractionation of cytosol and
Figure 3. miR-24 inhibits CHOP-induced Bim overexpression in ER mediated apoptosis pathway. (A) Validation of knockdown efficiency
using siRNA against ATF6, CHOP, JNK and XBP1 by qPCR. (B) miR-24 expression level was not altered upon knockdown of Caspase 3, Caspase 8,
Caspase 9, Caspase 12, ATF6, CHOP, JNK or XBP1. (C) Knockdown of CHOP but not other factors in the ER stress pathway partially rescued increased
apoptosis caused by miR-24 inhibition. *, p,0.05. Data were analyzed by unpaired Student’s t test. (D) PCR for Bim showing decreased Bim expression
upon CHOP knockdown. *, p,0.05. Data were analyzed by unpaired Student’s t test. (E) Western for Bim showing decreased Bim protein level when
CHOP siRNA was transfected into primary CMs. GAPDH serves as a loading control.
doi:10.1371/journal.pone.0085389.g003
miR-24 in Cardiomyocyte Apoptosis
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mitochondria respectively. We found that there appeared to be less
Bax in the mitochondrial fraction upon miR-24 expression in
primary cardiomyocytes. In contrast, there was an increase in
mitochondrial Bax upon miR-24 inhibition (Fig. 4C). Knocking-
down of Bim resulted in an increase in the amount of cytosolic Bax
compared to mitochondrial Bax (Fig. 4D), suggesting that miR-24
regulates Bax translocation in part through Bim. Interestingly, the
increase in cytosolic accumulation of Bax is more pronounced with
knocking-down of Bim compared to that of miR-24 mimic
treatment. This is consistent with our previous ‘‘over-rescue’’
observation that knocking down of Bim attenuated increased
apoptosis caused by miR-24 inhibition to a level that is even lower
than the basal level with control transfection [35], suggesting Bim
has its independent role in regulating intrinsic apoptosis that is not
controlled by miR-24. In contrast, manipulation of miR-24
resulted in limited changes in mRNA, protein expression levels
and cellular localization of other Bcl-2 family members such as
Bcl-2, indicating that Bcl-2 does not function in miR-24 mediated
Figure 4. miR-24 regulates mitochondria-mediated apoptosis pathway. (A) Overexpression of miR-24 suppresses cytochrome C release from
mitochondria to cytosol. Western blot for cyto.C in cytosol (C) or mitochondria (M) fractions of primary cardiomyocytes transfected with miR-24
mimic, inhibitor, or corresponding controls. Caspase 8 was used as a loading control for cytosol fraction; CoxIV was used as a protein marker for the
mitochondrial fraction. (B) qPCR for Bax mRNA from primary cardiomyocytes transfected with miR-24 mimic, inhibitor and corresponding controls. (C)
Western blot for Bax on cytosol (c) or mitochondrial (m) fractions of primary cardiomyocytes transfected with miR-24 mimic, inhibitor and
corresponding controls. (D) Western blot for Bax on cytosol (c) or mitochondrial (m) fractions of primary cardiomyocytes transfected with control or
Bim siRNAs. (E) qPCR for Bcl2 mRNA from cells transfected with miR-24 mimic, inhibitor or corresponding controls. (F) Western blot for Bcl2 protein
showing miR-24 did not regulate the protein level of Bcl2.
doi:10.1371/journal.pone.0085389.g004
miR-24 in Cardiomyocyte Apoptosis
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apoptosis (Fig4 E, F and data not shown). Taken together, these
findings reveal a function of miR-24 in repressing the mitochon-
drial apoptosis pathway by inhibiting Bax translocation to the
mitochondria.
Discussion
Here, we carefully examined the molecular/genetic pathways
by which miR-24 regulates programmed cell death in primary
cardiomycoytes. We showed that miR-24 modulated intrinsic
apoptosis by interacting with CHOP-mediated ER pathways and
by inhibiting cytochrome C release, and Bax translocation from
cytosol to mitochondria. miR-24 is up-regulated upon cardiac
stress in animal models and in humans [41] and may be mediating
a compensatory response under cardiac stress. Interestingly,
overexpression of miR-24 in primary cardiomyocytes was able to
induce hypertrophic growth [41]. Our findings suggest that miR-
24 regulation of intrinsic apoptosis pathways might contribute to
its ability to modulate apoptosis and possibly hypertrophic growth.
In this study, we demonstrated that Bim and its interacting
partners, such as CHOP and Bax, are the major downstream
mediators of miR-24 in inhibiting cardiomyocyte apoptosis.
However, since a number of pro- or anti-apoptotic genes appeared
not to be affected by miR-24 overexpression or inhibition (Figure
S2, Fig.4, and data not shown), it is likely that miR-24 represses
cell death in diseased hearts through a distinct mechanism that is
not part of the canonical apoptosis pathways. In addition, it is still
unclear how miR-24 and CHOP exert opposite effects on Bim
protein level, and how miR-24 regulates the release of Cyto-
chrome C and the translocation of Bax from cytosol to
mitochondria. We have not identified direct binding sites of
miR-24 in the UTRs of these genes, thus additional targets of
miR-24 might be involved in mediating its effects on Cytochrome
C and Bax protein translocation that awaits further characteriza-
tion.
In addition to its role in regulating apoptosis, miR-24 also
functions in the excitation-contraction (E-C) coupling process by
targeting the structural protein Junctophilin-2 expression in the
cardiomyocytes. Overexpression of miR-24 in the rat primary
cardiomyocytes resulted in defective E-C coupling. In a separate
study, inhibition of miR-24 was found to be protective on the
structural and functional integrity of the ion channel signaling in
the hypertrophic aortic-constricted hearts. These studies, in
addition to ours, further confirm the endogenous expression of
miR-24 in cardiomyocyte. In the heart, miR-24 is also expressed
in endothelial cells and cardiac fibroblasts. During myocardial
infarction, miR-24 regulates both vascularity and cardiac fibrosis.
Thus, this combinatorial effect of miR-24 in different cardiac cell
types of the infarcted heart could contribute to the significant
cardiac functional improvement upon introduction of miR-24 by
either in vivo transfection or virus transduction. Given the nature
of microRNAs, it is not surprising that one microRNA can play
multiple roles within one organ. However, how one function of
miR-24 is executed in a fine manner without interfering with its
other function is intriguing.
It is very interesting to note that the role of miR-24 in regulating
apoptosis is context-dependent. In certain cell types, such as
cardiomyocyte, neural retina and hematopoietic cells, miR-24 is
believed to repress apoptosis by inhibiting various pro-apoptotic
proteins. While in other cell types including endothelial cells, miR-
24 has been shown to target anti-apoptotic genes to promote cell
death. Therefore, when it comes to target miR-24 for therapeutic
interventions, the cell type specific context has to be considered.
Myocardial ischemia/infarction is a severe stress condition in
the heart that can cause significant loss of cardiomyocytes.
However, the mechanism that leads to cardiomyocyte apoptotic
cell death is only partly defined. Our findings that miR-24
modulates intrinsic apoptosis in murine primary cardiomyocytes
might open a new window for gaining additional insights into the
role of miRNAs in regulating stress-related heart diseases. In
addition, manipulating the expression level of miR-24 and/or its
downstream effectors in injured/failing heart may lead to
intervention of novel therapeutic strategies.
Supporting Information
Figure S1 Caspase 12 is not a direct target of miR-24.
Relative luciferase activity (RLA) in primary cardiomyoyctes
expressing the luciferase reporter with Caspase 12 39UTR and
miR-24 mimic, inhibitor, and corresponding controls. Controls
are set up as 1. The experiment was repeated three times with
biological triplicates (n = 3). Bar graphs show mean6SEM.
(TIF)
Figure S2 miR-24 does not regulate ATF6, XBP1, CHOP
and JNK in ER-mediated apoptosis pathway. (A) Overex-
pression of miR-24 mimic, inhibitor and corresponding controls
has minimal effect on the mRNA level of ATF6. (B) Western blot
for ATF6 from both cytosolic (c) and nuclear (n) fractions of
primary cardiomyocytes transfected with miR-24 mimic, inhibitor,
and corresponding controls. Actin was used as a loading control
for cytosol fraction; HP1a was used as a protein marker for
nucleus fraction. (C) RT-PCR showing unchanged proportion of
unspliced and spliced forms of XBP1 upon manipulation of miR-
24 levels. Samples treated with tunicamycin (Tun) served as
positive controls to show effective splicing of XBP1. GAPDH
serves as a loading control. (D) mRNA levels of CHOP (upper
panel) and JNK (lower panel) were not affected by introduction of
miR-24 mimic, inhibitor and corresponding controls. (E) miR-24
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